Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells

Cell Reports

Volumn 16, Issue 11, 2016, Pages 2838-2845

  Shtayer, Lior ^a,d   Tien, An Chi ^b   Szeto, Emily ^a   Sanai, Nader ^a   Rowitch, David H ^b,c   Mehta, Shwetal ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cancer stem cell; glioblastoma; growth factor; Olig2; receptor tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; NERVE PROTEIN; OLIG2 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; GLIOMA STEM CELL; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BRAIN TUMOR; CANCER STEM CELL; CELL CYCLE; CELL NUCLEUS; GLIOMA; MESODERM; METABOLISM; NEURAL STEM CELL; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN NEOPLASMS; CELL CYCLE; CELL LINEAGE; CELL NUCLEUS; GLIOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESODERM; MICE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84991707544     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.08.040     Document Type: Article

References (27)

1. Aguirre, A., Dupree, J.L., Mangin, J.M., Gallo, V., A functional role for EGFR signaling in myelination and remyelination. Nat. Neurosci. 10 (2007), 990–1002.
2. Alcantara Llaguno, S.R., Wang, Z., Sun, D., Chen, J., Xu, J., Kim, E., Hatanpaa, K.J., Raisanen, J.M., Burns, D.K., Johnson, J.E., Parada, L.F., Adult lineage-restricted CNS progenitors specify distinct glioblastoma subtypes. Cancer Cell 28 (2015), 429–440.
3. Bhat, K.P., Balasubramaniyan, V., Vaillant, B., Ezhilarasan, R., Hummelink, K., Hollingsworth, F., Wani, K., Heathcock, L., James, J.D., Goodman, L.D., et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell 24 (2013), 331–346.
4. Carén, H., Stricker, S.H., Bulstrode, H., Gagrica, S., Johnstone, E., Bartlett, T.E., Feber, A., Wilson, G., Teschendorff, A.E., Bertone, P., et al. Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell-cycle arrest. Stem Cell Reports 5 (2015), 829–842.
5. Carro, M.S., Lim, W.K., Alvarez, M.J., Bollo, R.J., Zhao, X., Snyder, E.Y., Sulman, E.P., Anne, S.L., Doetsch, F., Colman, H., et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463 (2010), 318–325.
6. Cloughesy, T.F., Cavenee, W.K., Mischel, P.S., Glioblastoma: from molecular pathology to targeted treatment. Annu. Rev. Pathol. 9 (2014), 1–25.
7. Gonzalez, C., Sims, J.S., Hornstein, N., Mela, A., Garcia, F., Lei, L., Gass, D.A., Amendolara, B., Bruce, J.N., Canoll, P., Sims, P.A., Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors. J. Neurosci. 34 (2014), 10924–10936.
8. Gonzalez-Perez, O., Romero-Rodriguez, R., Soriano-Navarro, M., Garcia-Verdugo, J.M., Alvarez-Buylla, A., Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells 27 (2009), 2032–2043.
9. Imayoshi, I., Kageyama, R., bHLH factors in self-renewal, multipotency, and fate choice of neural progenitor cells. Neuron 82 (2014), 9–23.
10. Imayoshi, I., Kageyama, R., Oscillatory control of bHLH factors in neural progenitors. Trends Neurosci. 37 (2014), 531–538.
11. Lathia, J.D., Mack, S.C., Mulkearns-Hubert, E.E., Valentim, C.L., Rich, J.N., Cancer stem cells in glioblastoma. Genes Dev. 29 (2015), 1203–1217.
12. Ligon, K.L., Alberta, J.A., Kho, A.T., Weiss, J., Kwaan, M.R., Nutt, C.L., Louis, D.N., Stiles, C.D., Rowitch, D.H., The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J. Neuropathol. Exp. Neurol. 63 (2004), 499–509.
13. Ligon, K.L., Huillard, E., Mehta, S., Kesari, S., Liu, H., Alberta, J.A., Bachoo, R.M., Kane, M., Louis, D.N., Depinho, R.A., et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 53 (2007), 503–517.
14. Liu, Y., Han, S.S., Wu, Y., Tuohy, T.M., Xue, H., Cai, J., Back, S.A., Sherman, L.S., Fischer, I., Rao, M.S., CD44 expression identifies astrocyte-restricted precursor cells. Dev. Biol. 276 (2004), 31–46.
15. Lu, F., Chen, Y., Zhao, C., Wang, H., He, D., Xu, L., Wang, J., He, X., Deng, Y., Lu, E.E., et al. Olig2-dependent reciprocal shift in PDGF and EGF receptor signaling regulates tumor phenotype and mitotic growth in malignant glioma. Cancer Cell 29 (2016), 669–683.
16. Mateo, J.L., van den Berg, D.L., Haeussler, M., Drechsel, D., Gaber, Z.B., Castro, D.S., Robson, P., Crawford, G.E., Flicek, P., Ettwiller, L., et al. Characterization of the neural stem cell gene regulatory network identifies OLIG2 as a multifunctional regulator of self-renewal. Genome Res. 25 (2015), 41–56.
17. Mehta, S., Huillard, E., Kesari, S., Maire, C.L., Golebiowski, D., Harrington, E.P., Alberta, J.A., Kane, M.F., Theisen, M., Ligon, K.L., et al. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell 19 (2011), 359–371.
18. Meijer, D.H., Kane, M.F., Mehta, S., Liu, H., Harrington, E., Taylor, C.M., Stiles, C.D., Rowitch, D.H., Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nat. Rev. Neurosci. 13 (2012), 819–831.
19. Meijer, D.H., Sun, Y., Liu, T., Kane, M.F., Alberta, J.A., Adelmant, G., Kupp, R., Marto, J.A., Rowitch, D.H., Nakatani, Y., et al. An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells. J. Neurosci. 34 (2014), 8507–8518.
20. Otero, J.J., Rowitch, D., Vandenberg, S., OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J. Neurooncol. 104 (2011), 423–438.
21. Ozawa, T., Riester, M., Cheng, Y.K., Huse, J.T., Squatrito, M., Helmy, K., Charles, N., Michor, F., Holland, E.C., Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell 26 (2014), 288–300.
22. Persson, A.I., Petritsch, C., Swartling, F.J., Itsara, M., Sim, F.J., Auvergne, R., Goldenberg, D.D., Vandenberg, S.R., Nguyen, K.N., Yakovenko, S., et al. Non-stem cell origin for oligodendroglioma. Cancer Cell 18 (2010), 669–682.
23. Singh, S.K., Fiorelli, R., Kupp, R., Rajan, S., Szeto, E., Lo Cascio, C., Maire, C.L., Sun, Y., Alberta, J.A., Eschbacher, J.M., et al. Post-translational modifications of OLIG2 regulate glioma invasion through the TGF-beta pathway. Cell Rep. 16 (2016), 950–966.
24. Snuderl, M., Fazlollahi, L., Le, L.P., Nitta, M., Zhelyazkova, B.H., Davidson, C.J., Akhavanfard, S., Cahill, D.P., Aldape, K.D., Betensky, R.A., et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20 (2011), 810–817.
25. Sun, Y., Meijer, D.H., Alberta, J.A., Mehta, S., Kane, M.F., Tien, A.C., Fu, H., Petryniak, M.A., Potter, G.B., Liu, Z., et al. Phosphorylation state of Olig2 regulates proliferation of neural progenitors. Neuron 69 (2011), 906–917.
26. Suvà, M.L., Rheinbay, E., Gillespie, S.M., Patel, A.P., Wakimoto, H., Rabkin, S.D., Riggi, N., Chi, A.S., Cahill, D.P., Nahed, B.V., et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157 (2014), 580–594.
27. Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Ding, L., Golub, T., Mesirov, J.P., et al., Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17 (2010), 98–110.